Results 61 to 70 of about 6,254 (213)

The development of immunosorbents for the treatment of systemic lupus erythematosus via hemoperfusion

open access: yesFrontiers in Medicine, 2023
Systemic lupus erythematosus (SLE) is an autoimmune disease (AID) that involves multiple organ systems and is characterized by elevated levels of autoantibodies (ANA) and immune complexes.
Yameng Yu, Yameng Yu, Lailiang Ou
doaj   +1 more source

A Novel Sequential Regimen of Efgartigimod and Telitacicept as Fast‐Acting Treatment for Impeding Crisis of MuSK‐MG

open access: yesImmunity, Inflammation and Disease, Volume 14, Issue 10, October 2026.
ABSTRACT Background Myasthenia gravis (MG) is an autoimmune disorder of the neuromuscular junction. The muscle‐specific kinase (MuSK) antibody‐positive subtype often involves bulbar and respiratory muscles, conferring a high risk of myasthenic crisis. Method We report a very late‐onset MuSK‐MG case complicated by lung infection and acute heart failure,
Tianjiao Duan   +3 more
wiley   +1 more source

Economic analysis of immunoadsorption systems

open access: yes, 2001
Immunoadsorption possesses an attractive combination of selectivity and yield, and in some cases may replace many conventional purification steps with a single step.
Ben Hunt   +9 more
core   +1 more source

IgE-Selective Immunoadsorption for Severe Atopic Dermatitis

open access: yesFrontiers in Medicine, 2018
IntroductionRecent reports proposed the application of immunoadsorption (IA) for patients with recalcitrant atopic dermatitis (AD) and high-serum IgE levels.
Michael Kasperkiewicz   +11 more
doaj   +1 more source

Practical Guidance on Initiating and Switching Targeted Immunotherapies in Generalised Myasthenia Gravis: A German–Austrian Expert Opinion Paper

open access: yesEuropean Journal of Neurology, Volume 33, Issue 9, September 2026.
ABSTRACT Background The therapeutic landscape of generalised myasthenia gravis (gMG) has evolved substantially with the approval of targeted immunotherapies, including complement C5 inhibitors (C5‐I) and neonatal Fc receptor inhibitors (FcRn‐I). While pivotal trials have demonstrated marked efficacy in defined subgroups, real‐world experience reveals ...
Andreas Meisel   +17 more
wiley   +1 more source

Identification of a Lactylation‐Related Gene Signature and Candidate Biomarkers for Dilated Cardiomyopathy

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 18, September 2026.
ABSTRACT Dilated cardiomyopathy (DCM) is a leading cause of heart failure. Due to its complex pathogenesis, effective treatment strategies remain limited. Therefore, it is particularly important to identify novel candidate biomarkers from the pathogenesis level. In recent years, lactylation modification plays an important role in various cardiovascular
Xiaoyan Zhi   +6 more
wiley   +1 more source

Staphylococcus Protein A-based Extracorporeal Immunoadsorption and Thalidomide in the Treatment of Skin Manifestation of Dermatomyositis:A Case Report

open access: yes, 2009
Cutaneous involvement in dermatomyositis can be the prevalent component of disease, failing to respond to adequate therapies for myositis. In this case report, we describe a patient affected by dermatomyositis, characterized by prevalent skin involvement,
Puccini R   +7 more
core   +2 more sources

A Critical Comparative Analysis of Immunoadsorption and Conventional Plasma Exchange in Preconditioning of ABO-incompatible Renal Transplant Cases

open access: yesIndian Journal of Transplantation
ABO-incompatible renal transplants often require expensive pre-transplant conditioning using therapeutic apheresis (TA) procedures to reduce the titers of isoagglutinins in the recipients, which may have adverse effects on the graft acceptance and ...
Prashant Pandey   +6 more
doaj   +1 more source

Protein A immunoadsorption combination with immunosuppressive therapy improves neuropsychiatric systemic lupus erythematosus: A case report

open access: yesClinical Case Reports, 2020
We described protein A immunoadsorption combination with immunosuppressive treatment improved rapidly a patient with Neuropsychiatric systemic lupus erythematosus.
Feng Wen   +15 more
doaj   +1 more source

Thai Transplant Care Practice Guideline on Immunosuppressive Therapy for Adult Kidney Transplantation

open access: yesNephrology, Volume 31, Issue S2, September 2026.
ABSTRACT The Thai Transplantation Society developed these clinical practice guidelines to establish a comprehensive standard for immunosuppressive therapy in adult kidney transplantation. While rooted in evidence‐based medicine, the objective of this document extends beyond local application, serving as a practical model for low‐to‐middle‐income ...
Suwasin Udomkarnjananun   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy